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A B S T R A C T
Patient deaths resulting from cardiovascular diseases are increasing across the globe, posing the greatest risk
to patients in developed countries. Myocardial infarction, as a result of inadequate blood flow to the my-
ocardium, results in irreversible loss of cardiomyocytes which can lead to heart failure. A sequela of myocar-
dial infarction is scar formation that can alter the normal myocardial architecture and result in arrhythmias.
Over the past decade, a myriad of tissue engineering approaches has been developed to fabricate engineered
scaffolds for repairing cardiac tissue. This paper highlights the recent application of electrically conductive
nanomaterials (carbon and gold-based nanomaterials, electroactive polymers) to the development of scaffolds
for cardiac tissue engineering. Moreover, this work summarizes the effects of these nanomaterials on cardiac
cell behavior such as proliferation and migration, as well as cardiomyogenic differentiation in stem cells.
© 2019.
1. Introduction
In the United States cardiovascular diseases (CVDs) are respon-
sible for one death every 40s [1]. Loss of blood circulation to re-
gions of the heart muscle due to coronary artery occlusion can dam-
age the myocardium, causing electrophysiological and morphological
disorders of the heart [2,3]. Ischemia may result in cardiac cell death
through necrosis, apoptosis, or autophagy and the subsequent forma
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tion of scar tissue reduces the cardiac contractile capacity [4]. Since
adult cardiomyocytes have a limited regenerative capacity, the dam-
age can be permanent and lead to heart failure and death [5]. Complex
surgical treatments have been developed over the past two decades
for cardiac transplantation; however, donor shortage is a major chal-
lenge that limits this approach. In addition, transplant patients must
receive immunosuppressive drug therapy after surgery to decrease
the risk of transplant rejection [5]. The disadvantages of heart trans-
plantations highlight the need for alternative therapies for the preven-
tion and remediation of cardiac failure. In the past decade, regenera-
tion of the heart, using approaches ranging from cell therapy to tis-
sue engineering, has been extensively investigated as an alternative
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in which different cell sources such as mesenchymal stem cells
(MSCs), induced pluripotent stem cells (iPSCs), and embryonic stem
cells (ESCs) [6–9] or their derivatives are used alone, or in combina-
tion, with scaffolds to treat the disease [10,11].
In the extracellular matrix (ECM) of the heart, collagen and elastin
form fibers which weave to compose a dense, elastic molecular net-
work. The micro- and nanoscale topography of the matrix causes me-
chanical coupling of cardiomyocytes, providing the unique electri-
cal and mechanical characteristics of the heart [12]. The biochemical,
electrical, and mechanical functions of the myocardial ECM are de-
pendent on its nanofeatures [13]. Cardiac tissue engineering can be
defined as the field that aims to generate or repair the myocardium
by combining knowledge and techniques from materials science, mi-
cro/nano-engineering, cellular biology, and biochemistry [14]. The re-
construction of effective cardiac tissue requires proper selection of
cell sources, establishment of the myocardial ECM, electromechanical
stimulation of cells, fabrication of robust contractile bundles, and in-
clusion of vascular channels.
Recently, there has been considerable effort to develop functional
scaffolds that are designed for cardiac repair, including cardiac
patches, injectables, and nanofibrous or nano-patterned scaffolds
[15,16]. To improve scaffold functionality, various nanomaterials in
the form of nanofibers [11,17–19], mesoporous and composite ma-
terials [20], nanoparticles [21], and modified nano-patterned surfaces
have been adopted. These technologies help recreate biomimetic mi-
croenvironments for cells to reach their full biological potential in the
engineering of a functional myocardium (Fig. 1).
Fabrication of scaffolds is influenced by the integration of chem-
ical, biological and physical properties [19,22]. An ideal scaffold
for cardiac tissue engineering must be electrically conductive, me-
chanically stable, biocompatible, topographically suitable, and possess
similar elasticity to the native myocardium [23,24]. The material’s
ability to propagate electrical impulses and translate them into syn-
chronized contractions is necessary to maintain circulation by pump-
ing blood through the organ [25]. Both the engineered cardiac con-
structs and injected cells must integrate into the electrical syncytium
Fig. 1. Representation of key factors for cardiac tissue regeneration. Induced pluripotent, mesenchymal, and embryonic stem cells have been used as cell sources for cardiogenic
differentiation using various protocols and growth factors. Mimicking the native cardiomyocyte microenvironment is also crucial for functional tissue regeneration – this can be done
by applying relevant mechanical and electrical stimulation through electrically conductive nanoscale scaffolds. Implementing these factors can help achieve dense populations of
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of the myocardium to maintain spontaneous contractile activity [26].
Electroactive biomaterials can transmit electromechanical, electro-
chemical, and electrical stimulation to cells [27]. In cardiac tissue en-
gineering, development and utilization of electroactive materials (con-
ductive polymers, piezoelectric materials, carbon nanotubes, carbon
nanofibers, as well as graphene and gold nanostructures) has been a
flourishing area of research in recent years. This review summarizes
the advancement of electroactive nanomaterials for cardiac regenera-
tion, and highlights the possibility of using these systems to regenerate
cardiac tissue (Fig. 2).
2. Biological response of cardiomyocytes to nanomaterials
It is important to understand the role of key genes and signaling
pathways in cardiac tissue development and function. These genes
and pathways play an important role in nanomaterial interaction with
cardiac cells. Cardiomyocytes are formed as a result of cardiac prog
enitor cell differentiation in the body in which several cardiac tran-
scription factors, such as Tbx5, Nkx-2.5, and GATA-4 help to ac-
tivate the transcription of structural genes for cardiomyocytes, such
as myosin heavy chain, desmin, cardiac troponins, and myosin light
chain [28]. The upregulation of these genes often occurs after 7days
of differentiation on two-dimensional (2D) culture systems. In partic-
ular, Nkx-2.5 is expressed in cardiomyocytes with positive cTnT after
10days of differentiation [29]. Major signaling pathways involved in
cardiac differentiation are BMP, FGF, Wnt, and TGFβ/Activin/Nodal
pathways. Other molecular pathways include Notch and p38 MAPK
signaling pathways [30]. Commonly used differentiation protocols re-
sult in a mixture of atrial, ventricular, and nodal cells [31]. How-
ever, it is possible to enrich a specific population of cardiomyocytes
compared to others. For example, it was shown that BMP antagonist
Grem2 is able to preferentially differentiate cardiomyocytes to atrial
cell type [32]. Nanomaterials can affect stem cell differentiation to-
ward cardiomyocytes. Moreover, they have shown great promise to
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maintain the function of primary cardiomyocytes in vitro and enhance
their function and survival in vivo.
Mechanical and electrical integrity of the heart is crucial for car-
diomyocyte function. The connexin (Cx) genes encode Cx proteins to
link cardiomyocytes in the heart. In particular, Cx43 is synthesized in
the plasma membrane of cardiomyocytes making intercellular chan-
nels between the cytoplasmic components of neighboring cardiomy-
ocytes [33]. Cx43 plays an important role in direct transferring signal-
ing molecules and ions from the cell membrane. These signaling mol-
ecules and ions regulate cell survival and intracellular calcium transi-
tion through releasing glutamate and ATP and electrical pulse prop-
agation [34]. Moreover, Cx43 localization on the cell membrane has
cardioprotective characteristic and avoids ischemia [35]. Electrically
conductive and mechanically strong nanomaterials have shown great
promise to connect individual cardiomyocytes resembling the role of
Cx43 in tissue development and function.
Cardiac tissues have been engineered using different sources of
cardiomyocytes [36]. Foetal and neonatal cardiomyocytes from ani-
mal models, such as rats and mice have largely been used in cardiac
tissue engineering as they are easy to obtain and have high regener-
ative ability [37]. These early stage cardiomyocytes have higher sur-
vival rate and regeneration capability compared to adult cardiomy-
ocytes [38]. However, there are some issues regarding the use of pri-
mary cardiomyocytes, such as immunogenicity, malignancy, and eth-
ical concern [39]. Nanomaterials can be helpful to remodel the mi-
croenvironment of primary cardiomyocytes in vitro and enhance their
survival and function in vivo. Differentiated cardiomyocytes from
stem cells, such as MSCs, iPSCs, and ESCs have also shown great
promise in cardiac tissue engineering [40]. In particular, cardiomy-
ocyte-derived iPSCs can be obtained from human fibroblasts to make
personalized tissue constructs. However, there is still required to en-
hance the efficiency of differentiation protocols to make highly pure
and functional cardiomyocytes. Here, nanomaterials can be useful in
regulating stem cell differentiation to cardiomyocytes. Moreover, they




Carbon nanotubes (CNTs) have been utilized extensively in bio-
medical and biological applications such as imaging, regenerative
medicine, and pharmaceutical applications like drug delivery [41–43].
CNTs are interesting candidates as substrates or additives in bioma-
terials for tissue regeneration due to their mechanical and electri-
cal properties [44,45]. These cylindrical nano-structured carbon mol-
ecules have a high aspect ratio. There are three classes of carbon
nanotubes based on the number of graphite cylinders in the struc-
ture: single-walled carbon nanotubes (SWCNTs, 1–2nm diameter),
double-walled carbon nanotubes (DWCNTs), and multi-walled carbon
nanotubes (MWCNTs, 10–100nm diameter). The electrical properties
of CNTs are influenced by the orientation and wrapping of the hexag-
onal bond structure. CNTs are known for their mechanical strength
and can be integrated into materials to increase the tensile strength
and Young’s modulus of composites [46]. There are many methods
available to produce CNTs including physical methods, like the elec-
tric-arc technique [47] and laser ablation [48], and chemical methods,
like chemical vapor deposition [49].
CNTs have been used for a wide variety of applications in cellular
biology ranging from in vivo cell tracking, labeling, and transfection
to improving the conductivity of scaffolds [21,50,51]. A major hurdle
to mass adoption of CNTs for biomedical applications was cytotoxi-
city [52–54]; however, advanced surface modifications have signifi-
cantly improved the biocompatibility of these nanotubes [55,56]. Due
to their biocompatibility and physical properties, CNTs are promis-
ing reinforcement materials and good conductive agents for cardiac
[57–59] and neural [60,61] tissue engineering [62]. Biocompatibility
of a purified suspension of CNTs interacting with mouse cardiomy-
ocytes (H9c2) has shown that cell viability was unaffected by the pres-
ence of CNTs for the first 3days (short-term biocompatibility). How-
ever, the long-term toxicity became apparent as apoptosis occurred af-
ter 3days of cell culture in the presence of the nanotubes [63].
In other studies, pure CNTs were deposited on glass surfaces to
investigate cardiomyocyte behavior. Martinelli et al. cultured neona-
tal rat cardiomyocytes on glass modified with MWCNTs (162nm di-
ameter). They discovered that the cardiomyocytes formed tight con-
tacts and showed enhanced proliferation. After 2–3days in culture,
shorter action potentials of cardiomyocytes in the presence of MW-
CNTs were reported [64]. In 2013, Martinelli and colleagues further
demonstrated that deposition of 20–30nm diameter MWCNTs on a
glass substrate can promote cardiomyocyte growth and differentiation
by altering gene expression and electrophysiological properties. MW-
CNTs (Fig. 3A.a) improved the electrophysiological characteristics
of the cardiomyocytes, enhanced intracellular calcium signaling (Fig.
3Ab), and accelerated the maturation of functional syncytia. The ex-
pression of the Cx43 gene (Fig. 3A.c) was also increased; suggesting
that CNTs may play a role in improving electrical conductivity by re-
inforcing electrical coupling between cardiomyocytes [65].
Liao et al. have demonstrated the production of MWCNT-incor-
porated polyvinyl alcohol (PVA)/chitosan nanofibers by electrospin-
ning. MWCNTs (30–70nm diameter and 100–400nm length) were in-
corporated in a blend of PVA and chitosan fibers (160nm diameter).
Incorporation of MWCNTs improved the protein adsorption ability of
the nanofibers (Fig. 3B.a) and significantly promoted cell prolifera-
tion and adhesion (Fig. 3B.b and c) [66]. Wickham and colleagues
have conjugated MWCNTs (7–15nm diameter) to the surface of hy-
drophobic polycaprolactone (PCL) sheets and nanofiber meshes via
thiophene. This group was able to increase the fiber’s mechanical
strength without changing the mesh morphology. The addition of thio-
phene-conjugated CNTs to PCL polymers also resulted in increased
proliferation of cardiac progenitor cells (CPCs) [67]. Incorporation of
CNTs in other materials, such as gelatin nanofibers and poly(glycerol
sebacate) (PGS), notably enhanced the alignment, mechanical tough-
ness, and electrical conductivity of fibers. The enhanced material re-
sulted in strong and synchronized beating of cardiomyocytes. By in-
corporating CNTs, the excitation threshold was 3.5 times lower and
expression of Cx43 in cardiomyocytes was higher. In addition, CNTs
add to the scaffold’s ability to mimic the anisotropic structure of the
left ventricle [68].
Incorporation of CNTs in nanofibrous scaffolds has also been ap-
plied to cardiomyogenic differentiation of stem cells. In one study, re-
searchers incorporated SWCNTs in electrospun PCL to fabricate an
electrically conductive nanoscale scaffold. They employed electrical
stimulation to effectively differentiate human mesenchymal stem cells
(hMSCs) into cardiomyocytes. The presence of CNTs resulted in elon-
gated morphology and upregulation of cardiac markers like Nkx-2.5,
Cx43, GATA-4, and cardiac troponin T (CTT) [59]. Another study
showed that MWCNT-doped PCL fibers can also enhance cardiac dif-
ferentiation of hMSCs under electrical stimulation. The ionic resis-
tance of doped fibers was measured through electrochemical imped-
ance spectroscopy and the optimum amount of incorporated CNTs










Advanced Drug Delivery Reviews xxx (xxxx) xxx-xxx 5
Fig. 3. Carbon-based nanomaterials in cardiac tissue engineering. (A) Instructing physiological growth and functionally mature syncytia using 20–30nm MWCNTs. (a) Scanning
electron microscopy (SEM) image of cardiac myocytes and MWCNT (b) Reported data for the kinetic properties of calcium events of cells cultured on gelatin and MWCNTs. (c)
Fluorescence images of cardiac myocytes, α-actinin (green), Cx43 (red) and nuclei (DAPI, blue). Distribution of Cx43 on the MWCNTs (left) and gelatin (right) scaffolds. Scale
bars = 50μm. Reprinted from [65]. (B) Improved cellular response of cardiac cells on the MWCNT-incorporated PVA/chitosan scaffolds (a) Incorporation of MWCNTs improved
nanofiber protein adsorption (b) PVA/chitosan nanofibrous mats without MWCNTs and (c) PVA/chitosan/MWCNTs nanofibrous mats. Reprinted from [66]. (C) CNT-chitosan scaf-
folds. (a) Fluorescence images of ventricular myocytes cultured on CNT-chitosan scaffolds. Cells stained for sarcomeres: α–actinin (green), gap junctions: Cx43 (red), and DNA.
SWCNTs addition enhanced synchronous beating (b) and conduction velocities (c). Reprinted from [69].
CNTs have also been integrated with hydrogels [71]. Hydrogels
and soft tissues have similar mechanical and structural properties.
Typical hydrogels, such as gelatin methacryloyl (GelMA), are also
biodegradable. In 2013, Shin et al. created controllable 3D biohybrid
actuators for electrical stimulation of neonatal rat cardiomyocytes.
They embedded aligned CNT (50–100nm diameter) forest microelec-
trode arrays into hydrogel plates of GelMA (50μm thickness) to con-
struct scaffolds with anisotropic electrical conductivity. Engineered
tissue showed better cell organization, higher cell-to-cell coupling,
and an increase in HL-1 cell maturation. Synchronized beating im-
proved and significant reductions in excitation thresholds were ob-
served. In this study, expression of troponin I and Cx43 was increased
and no toxic effects were observed for 7days [57]. In 2015, Elkhenany
et al. incorporated 2 and 5nm diameter MWCNTs in GelMA to fab-
ricate electrically conductive scaffolds for investigating cardiac cell
behavior under electrical stimulation (1 Hz, 5 V, 50ms pulse width).
They observed that overexpression of sarcomeric α-actinin and Cx43
led to improved cell behavior [72]. In another study, Pok et al. devel-
oped a scaffold containing subtoxic concentrations of SWCNTs (8nm
diameter × 262nm length) in a gelatin-chitosan hydrogel. Nanobridges
of SWCNTs between cardiac cells led to en
hanced expression of cardiac markers (Fig. 3C.a), synchronous beat-
ing (Fig. 3C.b), electrical coupling, and normal function of cardiomy-
ocytes. Excitation conduction velocities (Fig. 3C.c) of engineered tis-
sues were similar to that of natural myocardial tissue at 22± 9 cm/s
[69]. Yu et al. incorporated carboxyl-functionalized MWCNTs into
type I collagen hydrogels. They demonstrated that the rhythmic con-
traction area of neonatal rat cardiomyocytes increased due to the ad-
dition of CNTs [73]. In another study, Ahadian et al. fabricated a
series of moldable elastomeric scaffolds by incorporation of MWC-
NTs into a polyester called poly(octamethylene maleate (anhydride)
1,2,4-butanetricarboxylate). Their study demonstrated that scaffolds
composed of 0.5% CNTs could improve the excitation threshold in
neonatal rat cardiomyocytes [74]. Also, Ho et al. fabricated PCL/
MWCNT composite scaffolds for cardiac tissue engineering using
3D printing techniques [75]. This particular scaffold design offers
selective treatments for complex cardiac tissues. In another attempt,
Izadifar et al. fabricated hybrid cardiac patches by encapsulating hu-
man coronary artery endothelial cells in methacrylated collagen scaf-
folds with CNTs using a UV-integrated 3D bioprinting technique
[76]. Additional researchers attempted to build on this success by de-
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tions. In this regard, Roshanbinfar et al. fabricated an injectable, ther-
moresponsive, conductive scaffold by adding MWCNTs to pericardial
matrix hydrogel. Functionalized MWCNTs with carbodihydrazide im-
proved electrical and mechanical properties of the hydrogel, leading
to an increase in cell proliferation and expression of Cx43 [77]. More
recently, Cabiati et al. incorporated different concentrations of SW-
CNTs into gelatin-based genipin cross-linked scaffolds and observed
overexpression of cardiac markers in cardiomyoblasts [78].
3.2. Carbon nanofibers
Carbon nanofibers (CNFs) are hollow cylinders with diameters be-
tween 50 and 500nm and length on the order of microns. Because
of their high aspect ratio (length/diameter greater than 100), they
have been utilized for numerous applications. They have many unique
physical and mechanical properties including a tensile strength of ap-
proximately 3 GPa, Young’s modulus of 500 GPa, thermal conductiv-
ity of 1900Wm−1 K−1, electrical conductivity of approximately 103 S/
cm [79,80], in addition to compatibility with organochemical modifi-
cations [81]. CNFs have cup-stacked or platelet structures that are less
uniform compared to the hexagonal network of CNTs [82,83]. CNFs
are fabricated using one of two methods: catalytic thermal chemical
vapor deposition growth or electrospinning followed by heat treat-
ment. CNF-reinforced polymer scaffolds can also be fabricated by
easily dispersing the CNF in a polymer matrix, followed by either melt
mixing or sonication in low viscosity solutions [83]. Several studies
have mentioned applications of CNFs in neural [84,85], bone [86–89],
muscle [90], and cardiac regeneration [91–93].
Stout et al. investigated cardiomyocyte function on poly(lac-
tic-co-glycolic acid) (PLGA) and CNF composites. Their results re-
vealed that CNFs increased the conductivity and cytocompatibility
of PLGA and promoted cardiomyocyte adhesion and proliferation.
Also, the density of cardiomyocytes increased with CNFs (up to 25:75
wt% PLGA:CNFs). The electrical conductivity of PLGA/CNF com-
posites increased by adding CNFs of any diameter [91]. Meng et al. in-
troduced injectable, biomimetic, electrically conductive scaffolds us-
ing CNFs, self-assembled rosette nanotubes (RNTs), and poly(2-hy-
droxyethyl methacrylate) (pHEMA) hydrogel for myocardial tissue
engineering. As more CNFs and RNTs were incorporated into the
pHEMA matrix, cardiomyocyte density in the hydrogel increased.
Adding greater amounts of CNFs to the composites led to a decrease
in tensile modulus and contact angle, but increased conductivity and
surface roughness [92]. In order to mimic myocardial anisotropy, Asiri
et al. created patterns (20μm wide) of aligned CNFs (100nm diame-
ter) on the surface of PLGA (50:50 PGA:PLA weight ratio). The re-
sult showed that CNF alignment increased the density of cardiomy-
ocytes in the scaffold. Also, aligning the CNFs in the PLGA scaffold
increased the longitudinal (vertical) conductivity to 0.1 S/m and de-
creased the horizontal (transverse) conductivity to 0.0025 S/m com-
pared to a scaffold with randomly oriented fibers; these conductivities
are similar to those of natural heart tissue [93].
3.3. Graphene and its derivatives
Graphene is a freestanding, 2D active carbon allotrope. In
graphene, the hexagonal aromatic structure is achieved by covalent
bonds between each atom of carbon and three neighboring carbon
atoms within the 2D crystal. The unique physical and electrical prop-
erties of graphene and its derivatives make it an ideal material for
incorporation into composites to enhance desirable properties [94].
Moreover, the high surface area of graphene facilitates the ability to
load large quantities of bioactive compounds on its surface [95].
In vivo and in vitro biocompatibility of graphene and its derivatives
has been reported in multiple studies [96,97]. Different approaches
to improve biocompatibility such as oxidation, reduction, and func-
tionalization, as well as controlling the size of the product, have been
demonstrated [95,98]. Wang et al. found that cardiogenic differenti-
ation of human iPSCs could be improved by using superconductive
sheets of graphene [99]. In a recent study, Smith et al. developed mi-
cro- and nano-patterned conductive hybrid scaffolds using graphene
and polyethylene glycol (PEG). The anisotropic electrical conductiv-
ity and graphene-functionalized topography of these scaffolds led to
an enhancement in myofibrils and sarcomeric structures in addition to
an increase in electrical coupling of cardiac cells [100].
Graphene oxide (GO) is a highly oxidized form of graphene with
colloidal stability that behaves as surfactant-like, amphiphilic sheets
[101]. GO and reduced graphene oxide (rGO) have been used in com-
bination with different materials as tissue engineering scaffolds. rGO
has great conductivity and can also increase the hydrophobicity of
scaffolds [102]. Additionally, the biocompatibility of rGO makes it
a promising candidate for modifying bioprosthetic heart valves too
[95,102].
In one study, Shin et al., incorporated GO into GelMA hydro-
gels for creating a cell-laden scaffold to investigate fibroblast behav-
ior. Incorporation of GO significantly decreased the electrical im-
pedance at low frequencies [103]. In another study, the same group
used GO-based thin films and fabricated a 3D nano-structure through
a layer-by-layer (LbL) technique. GO sheets were coated with
poly-L-lysine (PLL). Neonatal rat ventricular cardiomyocytes be-
tween PLL and GO under electrical stimulation showed strong, spon-
taneous beating, cardiac cell organization, maturation, and cell-to-cell
electrical coupling [104]. Also, the incorporation of rGO into GelMA
hydrogels enhanced the electrical conductivity and mechanical prop-
erties of the material; the modified GelMA improved cardiomyocyte
viability, proliferation, and maturation in addition to inducing in-
creased spontaneous beating rates [105]. Incorporation of
graphene-based nanomaterials into hydrogels can improve both the
mechanical and electrical properties. These incorporations provide
nanotopography similar to natural in vivo environments, resulting in
better cell-to-cell signaling, and ameliorating signal propagation – all
of which are essential parameters in cardiac tissue engineering [95].
Table 1 gives a summary of carbon-based nanomaterials that have
been applied to cardiac tissue engineering.
4. Gold nanomaterials
Gold nanoparticles (AuNPs) have been studied extensively for
many biological and medical applications due to their controlled geo-
metrical, optical, and surface chemical properties [107]. Low cytotox-
icity and biocompatibility of AuNPs are demonstrated in several stud-
ies [108,109]. AuNPs can be synthesized in different shapes includ-
ing nanospheres, nanorods [110,111], tripods [112], tetrapods [112],
nanocubes [113], and nanocages [114]. They also can be transformed
into nanofibers, thin films, or nanoshells. Unique specific absorbance
spectra have been reported corresponding to different shapes of
AuNPs. A variety of geometries can be used for medical applications
including diagnosis, sensing, molecular imaging, and stem cell track-
ing. Additionally, the nanoparticles can be used to enhance the electri-
cal conductivity of nanocomposites. The ideal electrical conductivity,
acceptable biocompatibility, ease of surface modification, nanotopog-
raphy, and innate optic properties make AuNPs a desirable nanostruc-
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Table 1
Carbon-based nanomaterials in cardiac tissue engineering.
Material Electrical cues Scaffold Cell Results Limitations Year Ref.
Aqueous SWCNTs Not mentioned Pure CNTs/SWCNTs H9c2 - No short-term toxic-
ity









More negative resting and
action potential duration
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L929 - Increased cell prolif-
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Table 1 (Continued)
Material Electrical cues Scaffold Cell Results Limitations Year Ref.
electrically stimulation
(current of 0.15 V/cm and
frequency of 1 Hz) for
14-days)



















500 V/m, 5 ms duration,
frequency of 1 Hz) for
4-days






of scaffold was obtained
in 3% CNTs incorporation
- Elongated morphol-
ogy
- Elevated expression of










NRVC - Improved cell-cell
coupling








External electric field 1 V/









- Partial uniaxial alignment
of sarcomeric structures





square wave 1 Hz at 5 V
(50 ms pulse width)
GelMA/MWCNTs (2 and
5nm)









SWCNTs (0.8 nm × 262nm
length)






Not mentioned Type I collagen, MWCNTs
(30 ± 15nm × 5–20μm)
Neonatal rat
cardiomyocytes
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Table 1 (Continued)
Material Electrical cues Scaffold Cell Results Limitations Year Ref.
Not mentioned MWCNTs (










PCL with 3% CNTs (




Rat H9c2 cells - Myoblast cells at-
tached to the scaf-
folds in a healthy
condition for 4 days.
2016 [75]
PCL with 5% CNT (
Conductivity of 1.2 × 10−6
S/cm)
The electrical conductivity












- Increased cellular vi-
ability
Not mentioned SWCNTs (average diameter
of 50 nm), Gelatin





Shevach et al. have deposited AuNPs on decellularized omental
matrix in order to make an electrically conductive scaffold for car-
diac tissue engineering (Fig. 4A.a). Cardiac cells showed elongated
and aligned morphology and increased Cx43 expression. These hybrid
AuNP/omental patches demonstrated increased contraction force (Fig.
4A.b), lower excitation threshold, and boosted propagation of calcium
signals [115].
In another study, Fleischer et al. integrated AuNPs into PCL elec-
trospun fibers to fabricate an electroconductive nanocomposite scaf-
fold for myocardium tissue engineering. Cardiomyocytes in the pres-
ence of AuNPs, exhibited aligned and elongated morphology, stronger
contraction forces, and lower excitation thresholds in presence of
electrical fields [116]. Shevach et al. evaporated AuNPs (thickness
of 2, 4, and 14nm) to the surface of synthetic PCL-gelatin matrix
nanofibers (250nm diameter). This engineered hybrid nanocompos-
ite enhanced cardiomyocyte elongation, alignment, cardiac sarcom-
eric α-actinin expression, and resulted in higher cell contraction am-
plitudes and rates (Fig. 4B) [117].
Cardiomyogenic differentiation of stem cells also has been stud-
ied in AuNP-loaded nanofibrous scaffolds. In 2014, Ravichandran
et al. incorporated AuNPs into bovine serum albumin (BSA)/PVA
hybrid nanofibers. By culturing hMSCs on an AuNP-loaded con-
ductive nanofibrous scaffold with 5-azacytidine pre-treatment, car-
diomyogenic differentiation of hMSCs was remarkably enhanced
(Fig. 4C) [118]. In another study, Sridhar et al. incorporated different
materials such as AuNPs, vitamin B12, silk fibroin, and aloe vera in
a series of PCL scaffolds in which they co-cultured cardiomyocytes
and MSCs. The AuNP-blended scaffolds enhanced proliferation and
cardiomyogenic differentiation of MSCs. Functionalizing the bioma-
terials with AuNPs enhanced the mechanical strength of nanofibrous
scaffolds and resulted in better contractile characteristics for cardiac
cells [119].
Hydrogels are also good candidates for integrating gold nanocom-
posites to create 3D scaffolds. You et al. incorporated AuNPs ho-
mogeneously into a thiol-HEMA/HEMA hybrid hydrogel to mimic
physiological properties of natural myocardial ECM. Young’s mod-
ulus of the composite gel is closer to the in vivo myocardium in
comparison with naked polyaniline (PANI) and polypyrrole (PPy).
AuNPs enhanced expression of Cx43 in neonatal rat ventricular car-
diomyocytes (NRVC) in this hybrid scaffold [120]. Naseri et al. in-
corporated silica-gold core-shell spheres into PCL composite films;
the electrical conductivity of the scaffold was 1.51 S/cm. The particles
were composed of 20nm gold nanoshells covering silica microspheres
(1.1μm diameter) [121].
Dvir et al. demonstrated that the incorporation of gold nanowires
(30 nm diameter) with alginate could upregulate electrical and me-
chanical coupling proteins (like Cx43) to make better 3D cardiac
patches [122]. Cardiomyogenic differentiation of stem cells has also
been investigated in AuNP-incorporated hydrogels. In one study, Baei
and colleagues dispersed AuNPs into thermosensitive chitosan matri-
ces to make a conductive polymeric scaffold for cell stimulation. Their
results revealed a comparable level of viability, metabolism, migra-
tion, and proliferation of bone marrow-derived MSCs and relatively
high expression of cardiac-specific markers compared to chitosan hy-
drogel scaffolds without AuNPs. Also, electrical conductivity close
to that of the native myocardium (around 0.13 S/m) was observed
[123]. Ganji et al. incorporated gold nanowire/nanotubes into porous
polyurethane and fabricated biodegradable nanocomposites. Continu-
ous electrical stimulation of H9c2 cells cultured on these scaffolds fa-
cilitated increased confluency and myocardial expression of Nkx-2.5,
atrial natriuretic peptide, and natriuretic peptide precursor [124]. In
2016, Navaei et al. fabricated a new class of scaffolds by incorporat-
ing gold nanorods into GelMA hydrogels. These scaffolds raised the
expression of cardiac-specific markers including troponin I and sar-
comeric actinin from neonatal rat ventricular cardiomyocytes [125]. In
another study, Li et al. developed a hybrid scaffold from natural col-
lagen and AuNPs. They found that the presence of AuNPs regulated
the assembly of intercalated discs in cardiomyocytes via the β1 inte-
grin-mediated ILK/p-AKT/GATA4 pathway [126]. To accommodate
the use of new manufacturing technologies such as 3D printing, Zhu
et al. developed a conductive bioink by incorporating gold nanorods
into GelMA. These bioprinted constructs increased synchronized con-
traction and electrical propagation between cardiomyocytes [127].
Feiner et al. blended 3D nanocomposites with a complex elec-
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Fig. 4. Gold nanomaterials in cardiac tissue engineering. (A) Modifying the electrical properties of omental matrix using AuNPs (a) Decellularized omental matrix was decorated
with AuNPs using an e-beam evaporator. Cells were isolated from the same patient, placed on the scaffold for a personalized cardiac patch. (b) These hybrid scaffolds led to stronger
contraction forces generated by cardiomyocytes. (c) Deposition of AuNPs, with thicknesses of 4 and 10nm on the scaffold’s fibers, caused a color change in the scaffold. Reprinted
from [115]. (B) Increasing the matrix conductivity of microporous scaffolds by incorporating AuNPs. (a) AuNPs (2, 4, and 14nm) were evaporated on the surface of PCL-gelatin
nanofibers (250nm diameter). (b) Cardiac cells seeded in these scaffolds showed enhanced contraction amplitude and rate. Reprinted from [117]. (C) AuNPs incorporated into BSA/
PVA hybrid nanofibers remarkably enhanced cardiomyogenic differentiation of hMSCs. (a) The mechanism of crosslinking of AuNPs in bovine serum albumin (green) and AuNPs
(yellow). (b) Immunocytochemical results indicated gap junction protein expression, Cx43 (red), by differentiated contractile MSCs. DAPI: blue. Reprinted from [118]. (D) (a) A
blended 3D nanocomposite complex with embedded electronics for online monitoring of engineered cardiac patches. (b) Confocal microscope images of the assembled cardiac tissue
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sues. In order to sense the release of biomolecules and the electrical
activity in cells and tissues, a gold electrode-based device was inte-
grated with the electrospun scaffolds (Fig. 4D) [128]. Table 2 shows
different scaffolds incorporating AuNPs that have been fabricated for
cardiac tissue engineering applications.
5. Electroactive polymers
Electroactive polymers (EAPs) are smart materials with control-
lable conductive properties suitable for fabrication of electrically con-
ductive scaffolds. Their chemical, electrical, and physical properties
can be tuned by incorporating antibodies, enzymes, and other biologi
cal components to meet the requirements of the specific application.
Chemical and electrochemical synthesis are two main methods of
manufacturing conductive polymers [27]. Many polymers are not con-
ductive; therefore, they require a process called “doping” to transform
into a conductive material. PPy, PANI, and polythiophene (PTh) are
some important EAPs which have potential applications in cardiac tis-
sue engineering.
5.1. Polypyrrole
PPy is one of the best-known conductive polymers. Stimulus-re-
sponsive properties, in vitro and in vivo biocompatibility [132], ap
Table 2
Examples of the use of gold nanomaterials in cardiac tissue engineering.






AuNPs (4 and 10 nm) /
decellularized omental
matrices







Excitation threshold - More Cx43 expression - Non-degrada-
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Table 2 (Continued)
Material Electrical cues Scaffold Cells Results Limitations Year Ref.
Electrical conductivity of
scaffold was close to
native myocardium 0.13
S/m









Not mentioned GelMA hydrogel, gold
nanorods (average aspect ratio
of 3.15,16 ± 2/53 ± 4nm width
and length)
Cardiomyocytes - High cell retention 2016 [104]
- Improved cytoskeleton
organization
- Enhanced expression of
cardiac markers
(troponin I, sarcomeric α-
actinin)
Not mentioned Collagen and AuNPs Cardiac muscle
cells
- AuNPs regulates the as-
sembly of intercalated
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Electrical stimulation:
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H9c2 - Increased cell confluency 2016 [103]
- Up-regulation of myocar-
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functions
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propriate chemical stability, large specific surface area, and aptitude
for surface modifications to incorporate bioactive molecules [27]
make it an excellent candidate as a scaffold substrate for cardiac
tissue engineering. In 2007, Nishizawa et al. electrochemically de-
posited PPy films onto polyimide microelectrodes. In this study, pri-
mary cardiomyocytes formed sheets on these electrodes and displayed
synchronized beating upon non-invasive stimulation [133]. Spearman
et al. grew PPy films within PCL (treated with sodium hydroxide)
films in order to form functional sheets of cardiac cells. Cardiomy-
ocytes demonstrated an increase in Cx43 expression, faster calcium
transfer, and lower calcium transient durations. The surface re
sistivity of the PCL/PPy film was 1.0± 0.4 kΩ cm [134]. In order to
optimize PPy biomaterials for CPCs, Puckert et al. investigated the ef-
fect of surface properties on the viability of CPCs. The effect of dif-
ferent dopants on electroactivity of PPy was investigated using cyclic
voltammetry (CV). The group established fabrication parameters to
control the surface energy, morphology, and roughness of the materi-
als [135].
In 2015, Gelmi and colleagues deposited chlorine doped-PPy on
electrospun PLGA fibers to make 3D, electrically conductive scaf-
folds. Data confirmed biocompatibility of these scaffolds using car-
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PPy/PCL gelatin, electrospun, nanofiber scaffolds could not only im-
prove the overall function of cardiomyocytes, but also increase the ex-
pression of cardiac-functional proteins (α-actinin, troponin T, Cx43).
They also observed that incremental increases of PPy concentration
could decrease nanofiber diameter and increase the tensile modulus of
the scaffold. The nanofibers were measured to have an electrical con-
ductivity between 0.01 and 0.37 mS/cm [137].
In 2015, Mihic et al. conjugated PPy to chitosan and developed a
semi-conductive hydrogel (Fig. 5A.a). In vitro cardiomyocyte studies
demonstrated faster calcium transfer and lower calcium transient du
rations (Fig. 5A.b and d). By increasing the amount of PPy in PPy-chi-
tosan hydrogels, the electrical conductivity increased. In vivo stud-
ies showed a decrease in the QRS (one of three main waveforms in
heart electrocardiograms) interval, an increase in the transverse acti-
vation velocity, and significantly higher action potential amplitudes
compared to un-grafted chitosan [129]. Recently, Wang et al. fabri-
cated a conductive cryogel by integrating PPy nanoparticles, GelMA,
and PEG diacrylate (PEGDA) using a mussel-inspired dopamine
crosslinker. The in vitro and in vivo studies showed that migration of
PPy nanoparticles from the scaffold to cardiomyocytes resulted in ex
Fig. 5. EAPs in cardiac tissue engineering. (A) PPy conjugated to chitosan formed a semi-conductive hydrogel to enhance Cx43 expression, faster calcium transfer, and lower cal-
cium transient durations in cardiomyocytes. (a) PPy monomers grafting and cross-linking into a hydrogel. (b) Determination of the contraction threshold voltage was performed by
anion-contact stimulation of a single skeletal muscle. PPy-chitosan has a lower threshold voltage than chitosan. (c) A normal morphology was observed in the SEM images of rat
smooth muscle cells which were plated on polystyrene, chitosan, or PPy-chitosan. Scale bars = 500μm. (d) Faster transient velocity was observed for calcium in rat neonatal car-
diomyocytes which were plated on PPy-chitosan. Reprinted from [129]. (B) PANI-PLGA aligned fibers develop a 3D environment for synchronous beating of cardiomyocytes and
increasing expression of Gap Junction proteins. (a, b) Synthesis, seeding, and stimulation of the PANI/PLGA nanofibrous mesh for synchronous cell beating. (c) Fluorescence images
of neonatal rat cardiomyocytes cultured on meshes (cardiac troponin I is green, Cx43 is blue, and nuclei are red). Reprinted from [130]. Scale bar = 100μm. (C) Cardiomyocytes
adhered well to piezoelectric scaffolds made by electrospinning PVDF and PVDF-TrFE. (a) SEM image of a PVDF-TrFE scaffold with aligned fibers. Scale bar is 2μm. (b) Aligned
actin filaments with well-placed sarcomeres. F-actin is stained red and DAPI-stained nuclei are blue. Scale bar = 10μm. (c) Expression of cTnT, MHC, and Cx43 in cardiomyocytes
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cellent synchronous contraction and a reduction in infarct size [138].
In another study, Gelmi et al. coated PLGA fibers with PPy and made
a biocompatible, electroactive scaffold for cardiogenic differentiation
of human iPSCs under electromechanical stimulation [139].
5.2. Polyaniline
PANI is the oxidative polymeric product of aniline [140] and ex-
ists in different systems according to its oxidation level. Pernigrani-
line (fully oxidized base), emeraldine (half-oxidized base), and leu-
coemeraldine (reduced base) are some forms. Emaraldine is conduc-
tive and is the most stable form. PANIs are not only easy to synthe-
size, but also have good stability. Moreover, they are cost efficient and
able to be both electrically conductive or resistant [27]. Many synthe-
sis methods for nano/micro-fabrication of PANI have also been pub-
lished [141]. However, PANI is not suitable for many biological ap-
plications as it is inflexible and biodegradable, making it difficult to
integrate into soft cardiac tissue. Data from implantations that have
been performed yielded reports of chronic inflammation in tissues due
to PANI [142,143]. In addition to those discussed, many other stud-
ies have been conducted on cellular interactions with PANI in nerve,
muscle, and cardiac tissue engineering [144–146].
In 2006, Bidez et al. investigated adhesion and growth and prolif-
eration of cardiac H9c2 myoblasts cultured on PANI films for 200h.
In the first 100h, the doubling time increased. Also, results showed
that this scaffold, when in a physiological environment, maintained its
conductivity for the first 100h; however, its conductivity gradually de-
creased over time [147].
To ameliorate the scaffold’s biocompatibility, scientists have com-
bined PANI with different biological materials. Li and his colleagues
produced a nanofibrous blend based on co-electrospinning PANI and
gelatin as a smart scaffold. PANI was doped with camphorsulfonic
acid to form emeraldine PANI. Their results revealed that increas-
ing the amount of PANI in the mixture led to reduced fiber diameter
and increased tensile modulus. This biocompatible scaffold supports
attachment, migration, and proliferation of cardiac myoblasts. Also,
the conductivity of pure gelatin was determined to be 0.005 S/cm;
however, by increasing PANI composition, the conductivity increased
about four-fold [148]. Fernandes et al. modified PANI nanofibrous
scaffolds (69–80nm diameter) with hyper-branched PLL dendrimers
(4.5 nm diameter) [149]. In this study, neonatal rat heart cells showed
high biocompatibility and better proliferation with electrical stimula-
tion in the scaffold. To improve the hydrophilic properties of PANI
nanotubes, Moura et al. functionalized them with highly hydrophilic
polyglycerol dendrimers (80–180nm diameter); this modification al-
lowed the scaffold to support cardiac cell proliferation and adhesion
[150].
Hsiao et al. synthetized PANI-PLGA aligned fibers to develop
a 3D environment for synchronous beating of cardiomyocytes (Fig.
5B.a and b). Data showed that this scaffold increased the expres-
sion of gap junction protein (Cx43) and troponin T (Fig. 5B.c). Car-
diomyocytes formed isolated cell clusters and beat synchronously.
HCl-doped PANI increased electrical conductivity, attracted posi-
tively charged cell membrane proteins, and improved adhesion [130].
Borriello et al. used electrospun PANI with biocompatible PCL to
make an electrically conductive nanocomposite scaffold. The scaffold
promoted hMSC differentiation into cardiomyocyte-like cells [142].
Recently, attempts have been made to incorporate PANI into dif-
ferent hydrogels and polymers in order to yield electrically conduc-
tive properties. In 2013, Cui and his colleagues cultured cardiomy-
ocytes, fibroblasts, and osteoblasts inside an injectable hydrogel made
of a polylactide-poly(ethylene glycol)-polylactide (PLA-PEG-
PLA) copolymer coated with Tetra aniline (with carboxylate mod-
ification). Electrical stimulation was applied directly to Tetra ani-
line conductive samples and enhanced proliferation of all three cell
lines was observed [151]. Qazi et al. produced a conductive cardiac
patch by solvent casting PANI doped with camphorsulfonic acid and
blended with PGS. The fabricated scaffold demonstrated good bio-
compatibility and supported attachment, growth, and proliferation of
C2C12 myoblasts. After 4days, the conductivity of the samples was
similar to that of the native myocardium [152].
Baheiraei et al. embedded oligoaniline-polyurethane into PCL
films to fabricate an electroactive biocompatible scaffold supporting
cell proliferation and attachment. The electrical conductivity was on
the order of 10−5 S/cm [153]. In 2015, Baheiraei et al. also investigated
cardiomyocyte behavior in this scaffold. They observed increased ac-
tivity of cardiac-specific genes, actinin alpha 4 (Actn4) and troponin
T-2, on the conductive substrate, even in the absence of electrical
stimulation [154]. Dong et al. fabricated antibacterial, self-healing,
electroactive hydrogels by combining chitosan-graft-aniline tetramers
with dibenzaldehyde-terminated PEG at physiological conditions. The
data demonstrated that the fabricated electroactive hydrogel was bio-
compatible, injectable, and biodegradable. Additionally, the hydrogel
was determined to have an electrical conductivity around 10–3 S/cm
[155].
5.3. Piezoelectric polymeric materials
Piezoelectric materials generate electrical fields upon the applica-
tion of mechanical stress and can apply mechanical force in the pres-
ence of an electric field [156]. In piezoelectric materials, electric fields
are created without an external power source; however, there are lim-
itations on control over the stimulus [27]. There are some studies on
piezoelectric scaffolds in nerve [157], skeletal muscle [158], and car-
diac tissue engineering. Weber et al. investigated in vitro cytocom-
patibility of piezoelectric, electrospun poly(vinylidene fluoride–triflu-
oroethylene) (PVDF-TrFE) scaffolds [159]. Hitscherich et al. devel-
oped piezoelectric scaffolds by electrospinning polyvinylidene fluo-
ride (PVDF) and PVDF-TrFE (Fig. 5C.a). Mouse embryonic stem
cell-derived cardiomyocytes adhered well to this scaffold and im-
pulsively contracted, exhibited well-placed sarcomeres, and produced
cardiac-specific markers including myosin heavy chain, CTT, and
Cx43 (Fig. 5C.b and c) [131]. Table 3 provides a summary of scaffolds
based on electroactive polymers applied to cardiac tissue engineering.
6. Biocompatibility of electrically conductive nanomaterials
Although each material offers suitable electrical properties for car-
diac tissue engineering, the biocompatibility of the materials varies
greatly. While the potential applications of carbon-based nanomateri-
als continue to expand, their biocompatibility may prevent their use.
Several studies have been published showing mixed biological re-
sponses to the materials. Lung toxicity to varying extents has been
shown for both SWCNTs [54,160] and MWCNTs [53]. Each study
found an inflammatory response to the CNTs in addition to gran-
ulation around the particles. It is believed that these inflammatory
responses are due to long, biopersistent carbon nanotubes that are
not completely cleared by the immune system [161]. Other studies
focusing on cytotoxicity have shown contrasting evidence. A study
on human embryonic kidney cells reported toxicity as SWCNTs in-
hibited cell growth by reducing cell adhesion and inducing apop-
tosis [162]. Cell cycle and biochip analyses showed that the nan-
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Table 3
Summary of the electroactive polymer scaffolds used in cardiac tissue engineering.
Material Electrical properties Scaffold Cell Result Year Ref.







- Adhesive strength of PPy film
enhanced
2007 [133]
- Cells showed synchronized
beating upon stimulation
The surface resistivity PCL/PPy 1.00 ± 0.40 KΩ.cm PCL films/PPy HL-1 - Functional cardiac cell sheets
formed
2015 [134]
- Increased in Cx43 expression
- Faster Calcium transfer
- Lower calcium transient dura-
tions
Effect of different dopants on electroactivity of
PPy though cyclic voltammetry (CV)








CPCs/iPSCs - Confirmed biocompatibility 2015 [136]
Electrical conductivity 0.01– 0.37 mS/cm PCL/Gelatin fibers/





- Improved attachment, prolif-
eration,
2011 [137]
- Enhanced expression of car-
diac-functional protein (α-ac-
tinin, Troponin T, Cx43)
By increase the rate of PPy in PPy/Chitosan
hydrogel, the electrical conductivity increase
Chitosan Rat smooth muscle
cells
- In vitro: increased Cx43 ex-
pression, faster calcium trans-
fer and lower calcium tran-
sient durations.
2015 [129]
- In vivo: decreasing in the
QRS interval, increasing in
the transverse activation ve-
locity




- In vitro: higher level Cx43 ex-
pression, and α-actinin
2016 [138]
Gelatin-methacrylate - In vivo: immobilizing car-
diomyocytes into scaffolds





with a layer of PPy
(320nm and 0.49μm)
Human iPSCs - With excellent cell viability,
over expression of cardiomy-
ocyte specific genes (Actinin,
NKX2.5, GATA4, Myh6, c-
kit)
2016 [139]
Poly aniline Surface resistivity (non-conductive PANI) higher
than 10 MΩ/square
PANI H9c2 - Enhanced cell attachment and
growth on PANI films
2006 [147]
After partial de-doping, resistivity 2 kΩ/square
Conductivity of pure gelatin 0.005 S/cm Blend: Gelatin/PANI
(61± 13nm fiber)
H9c2 - Biocompatible 2006 [148]
By increasing PANI the conductivity increased
four fold
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Table 3 (Continued)
Material Electrical properties Scaffold Cell Result Year Ref.
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fibronectin, collagen IV) and increased expression of apoptosis-asso-
ciated genes. However, another study by Tamura concluded that the
cytotoxic effects were related strictly to the size of the nanoparticles,
and that the CNTs are not inherently toxic [163]. The study focused
on neutrophil response to titanium oxide particles and CNTs in blood
and concluded that toxicity is primarily related particle size under
3μm. The reason for the variation in these results likely lies within the
broad range of sizes and concentrations of the nanotubes being stud-
ied; therefore, the toxicity of CNTs should be tested in each applica-
tion prior to integration.
Another study compared the toxicity of carbon nanotubes to car-
bon nanofibers in human lung cancer cell lines [164]. The team con-
ducted in vitro analysis observing cell proliferation and morphology;
they found that carbon nanofibers were significantly more toxic than
nanotubes. Much of the research on carbon nanotube and nanofiber
cytotoxicity has been performed on various models of the lungs as in-
halation is a common method of exposure. Cardiac cells seeded with
these nanomaterials in scaffolds may behave differently. Addition
ally, modulating the size and length of the materials is essential to
achieving appropriate biocompatibility. Like other carbon-based
nanomaterials, graphene has also been shown to have limited biocom-
patibility. A 2012 study by Li, et al. demonstrated the cytotoxic effects
of pristine graphene on macrophages [165]. Murine macrophage-like
RAW 264.7 cells were cultured with various concentrations of dis-
solved, unmodified graphene. Strong dose-dependent toxicity was ob-
served. Although unmodified graphene is limited, chemically modi-
fied graphene has been shown to improve the compatibility with car-
diac tissue engineering by oxidizing [166–168], reducing [169], and
functionalizing [170,171] the surface.
Unlike carbon-based nanomaterials, materials using gold have
shown remarkable compatibility in many studies. Shukla et al. showed
that gold nanoparticles did not have any adverse biological impact
and are biocompatible when studied with macrophages [172]. The
cytotoxicity of the nanoparticles on RAW 264.7 macrophages was
studied with the MTT assay; the macrophages maintained viability
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the cytocompatibility of the nanoparticles with tethered ionic side
chains [173]. They found that cationic modifications increased cyto-
toxicity while anionic molecules showed little to no negative effects.
The biocompatibility of electroactive polymers varies significantly
depending the specific polymer(s) used. Polymers such as PPy have
been shown to be biocompatible with limited inflammatory response
after implantation in vivo [132]. The material was tested in vivo and
in vitro on rat peripheral nerve tissue and was observed to be bio-
compatible and a viable polymer for repairing nerve damage in rats.
PANI has also been studied and has shown great biocompatibility with
H9c2 cardiac myoblasts [147]. While an initial reduction in growth
and adhesion was observed, morphologically identical monolayers
were formed on PANI-coated surfaces compared to polystyrene sur-
faces after 6days. Additionally, the polymer maintained conductivity
for 100h after coating. Another study on polylactide-aniline pentamer
(PLAAP) copolymers also demonstrated excellent cytocompatibility
with rat glioma cells [143]. Cell viability (measured with the MTT
assay) was highest for cells cultured on PLAAP compared to PLA
and aniline pentamer (AP) individually. The last electroactive polymer
discussed in this review was PVDF-TrFE; a study found that human
skin fibroblasts proliferate normally on PVDF-TrFE in comparison to
those cultured on treated polystyrene in vitro [159].
For these materials to be used in cardiac tissue engineering, it is
imperative that they have the necessary physical, electrical, and bio-
logical properties. For some materials, such as graphene, simple mod-
ifications can be made to tailor the surface for the specific applica-
tion; however, other materials may have inherent limitations that im-
pair their utility as conductive materials for tissue engineering.
7. Concluding remarks and future challenges
Cardiovascular disease, involving the heart and/or blood vessels, is
a primary cause of death in the 21st century. Cardiac tissue engineer-
ing has the potential to introduce suitable materials and procedures
to serve as innovative alternative treatment strategies to heart trans-
plantation. Despite the considerable achievements in recent years, sci-
entists have faced many limitations in creating functional, engineered
myocardium tissue at clinical levels [174]. Promoting the electrical
integration of an engineered tissue with the host myocardium can
help restore functionality in a failing heart. Regulated beating of the
heart is highly dependent on the structure and chemistry of the ECM.
Engineered cardiac scaffolds require mimicked anisotropic structure
of native myocardial ECM, electrical conductivity of the cardiac tis-
sue (0.16 S/m longitudinally and 0.005 S/m transversely), and recre-
ation of the unique mechanical properties of the myocardium (highly
aligned collagen nanofibers 10–100nm) that can be obtained by tun-
ing the scaffold’s biochemical, biophysical, and topographical fea-
tures. There have also been attempts to apply frequent, regular electri-
cal stimulation to growing tissues, resulting more efficient engineered
cardiac patches.
Tissue engineering scaffolds containing electrically conductive
nanostructured materials are able to mimic the myocardial ECM
[175]. Moreover, they have been proven to support electromechani-
cal integration of cardiomyocytes within the host myocardium after
transplantation. There are a wide range of conductive nanostructured
materials for cardiac tissue engineering; these include carbon-based
nanomaterials (CNTs, CNFs, and graphene), gold-based nanomateri-
als, and electroactive polymers (such as PANI, PPy, and piezoelec-
tric polymeric materials). Apart from developments in the chemistry
of scaffolds, the fabrication techniques are also moving forward from
conventional methods to innovative 3D manufacturing. Scientists
from many disciplines are trying to facilitate cardiomyocyte com-
munication through a myriad of strategies including electrically con-
ductive scaffolds and gene transfer techniques. The ultimate goal in
cardiac tissue engineering is to induce the creation of specific car-
diac gap junction proteins to enable the production of functional tis-
sue constructs. Substantial interest in the scientific community has re-
volved around the use of electroactive nanostructured materials due
to their great potential in cardiac tissue engineering. In addition,
state-of-the-art fabrication techniques will assist electrically conduc-
tive scaffolds for improved functionality. Although nanostructured
gold particles, carbon-family materials, and electroactive polymers
have shed light on the preparation of promising scaffolds and patches,
there are still unexplored biomaterials and fabrication strategies with
potential to revolutionize the field. There are still many unanswered
questions regarding different aspects of these biomaterials such as
their cytotoxicity, biodegradability, injectability, and aptitude for sur-
face functionalization. Moreover, it is important to better explore
the effects of these biomaterials on differentiation of cardiomyogenic
stem cells, their adherence, elongation, orientation, and functional
properties as these properties relate to the development of functional
cardiac tissue. Undoubtedly, more investigation on the use of electri-
cally conductive nanostructured materials in cardiac tissue engineer-
ing must be pursued to answer the critical questions in the field. Due
to the interdisciplinary nature of the field, materials scientists, biolo-
gists, engineers, and physicians should work together to develop new
technology in the pursuit of surmounting the challenges of cardiac tis-
sue engineering.
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